Endpoints News

John D. Carroll is a biotech analyst and writer with decades of prize-winning experience in journalism. A co-founder of Endpoints News, he has covered biopharma for the past 17 years. Aside from his daily industry coverage for FierceBiotech, where he was named editor in 2003, leaving in 2016, Carroll has been a regular speaker at biotech events aro... und the globe. Hes been quoted by The New York Times, The New Yorker, Financial Times, The Times of London and more. Hes also keynoted at biotech gatherings around the world and addressed student audiences at MIT and Harvard. Carroll has contributed stories from Central America and Ireland to the Dallas Morning News and Time and wrote for the Houston Press. He spent 6 years as editor and publisher of the Dallas Business Journal, was publisher of Texas Business and early in his career was part of a Pulitzer Prize-winning team of reporters and editors at the Kansas City Star & Times. Arsalan Arif is a news media entrepreneur who set out to build his vision of an independent biotech news company at Endpoints News. His primary responsibility at Endpoints is the business model, followed by talent recruitment and product development. His journalism duties includes editing Endpoints' Early Edition and reporting on the biopharma cybersecurity beat. The son of immigrant entrepreneurs, he received his business education by watching his parents run brick-and-mortar stores in Kansas. Before founding Endpoints, Arsalan was the group publisher of FierceBiotech and FiercePharma. Born and raised in the aviation capital of the world Wichita Arsalan has been a private pilot for 20 years. After spending most of his adult life in Washington, DC, he now lives in Lawrence, Kansas, with his family. Shehla has been at Endpoints since its inception, forming the first systems and processes during the startup stage. In the early days, she contributed news items, established early editorial processes alongside handling sales, accounting and operations. As the company grew, she moved to lead ...Read More